Navigation Links
Chemotherapy's Effects on the Brain

Cancer survivors now have an explanation for their mental fog and forgetfulness and can no longer explain it away as a figment of their imagination//.

A new UCLA study shows that chemotherapy causes changes to the brain's metabolism and blood flow that can linger at least 10 years after treatment. Reported Oct. 5 in the online edition of the journal Breast Cancer Research and Treatment, the findings may help to explain the disrupted thought processes and confusion that plague many chemotherapy patients.

"People with 'chemo brain' often can't focus, remember things or multitask the way they did before chemotherapy," explained Dr. Daniel Silverman, head of neuronuclear imaging and associate professor of molecular and medical pharmacology at the David Geffen School of Medicine at UCLA. "Our study demonstrates for the first time that patients suffering from these cognitive symptoms have specific alterations in brain metabolism."

Silverman and his colleagues used positron emission tomography (PET) to scan the brains of 21 women who had undergone surgery to remove breast tumors five to 10 years earlier. Sixteen of them had been treated with chemotherapy regimens near the time of their surgeries to reduce the risk of cancer recurrence.

The team compared PET images evaluating the chemotherapy patients' brain function to PET scans from five breast-cancer patients who underwent surgery only, and 13 control subjects who did not have breast cancer or chemotherapy.

As the women performed a series of short-term memory exercises, the UCLA team measured blood flow to their brains. The researchers also ran a scan of the patients' resting brain metabolism after the women finished the exercises.

"The PET scans show a link between chemo-brain symptoms and lower metabolism in a key region of the frontal cortex," explained Silverman, a member of UCLA's Jonsson Comprehensive Cancer Center. "We found that the lower the patient's resting brain metabolism rate was, the more difficulty she had performing the memory test."

The scans revealed that blood flow to the frontal cortex and cerebellum spiked as the chemotherapy patients performed the memory tests, indicating a rapid jump in these brain regions' activity level.

"The same area of the frontal lobe that showed lower resting metabolism displayed a substantial leap in activity when the patients were performing the memory exercise," said Silverman. "In effect, these women's brains were working harder than the control subjects' to recall the same information."

Finally, the researchers discovered that women who underwent hormonal therapy in addition to chemotherapy displayed changes to their basal ganglia, a part of the brain that works to bridge thought and action. On average, these women showed an 8 percent drop in resting metabolism in this brain region.

"Chemotherapy used to be prescribed primarily to treat metastatic disease," observed Silverman. "Now it's common for doctors to administer chemotherapy to patients near the time of surgery to prevent metastasis. As many of these patients become long-term survivors, doctors are recognizing lasting side-effects of chemotherapy, and, in particular, the kind of chemo-brain symptoms we are studying."

"Our findings suggest that PET scans could be used to monitor the effects of chemotherapy on brain metabolism," he added. "The approach could be easily added to current whole-body PET or PET/CT scans already being used to monitor patients for tumor response to therapy."

Although chemo brain is an acknowledged phenomenon, doctors don't know what mechanisms cause it. More studies are needed to uncover how the damage occurs and whether modification of chemotherapy drugs could prevent it.

The National Cancer Institute recently awarded a five-year grant to oncologist Dr. Patricia Ganz, who is organizing a lo ng-term study on chemo brain of a larger group of breast-cancer survivors with Silverman and their colleagues at UCLA.

More than 211,000 new cases of breast cancer are diagnosed a year, making it the most common cancer in women. Experts estimate that at least 25 percent of chemotherapy patients are affected by chemo brain, and a recent study by the University of Minnesota reported an 82 percent rate.


Related medicine news :

1. Acupuncture May Help Chemotherapy Side Effects
2. Chemotherapy Pill Has Fewer Side Effects Than IV
3. Therapy Boosts Chemotherapy Effects
4. Smoking and its Effects
5. Reducing The After Effects of Tonsillectomy
6. The Side Effects Of Estrogen Therapy
7. The Harmful Effects Of Cigarette Smoke
8. Lung Therapy Found To Have Long-Term Side Effects
9. The Effects Of Estrogen Therapy
10. The After Effects Of Pneumonia
11. The Effects Of Dental X-Rays During Pregnancy Questioned
Post Your Comments:

(Date:10/13/2017)... ... October 13, 2017 , ... ... that offers insurance and financial preparation services, is providing an update on a ... organization. , Rock City Rescue is a locally recognized nonprofit that provides shelter ...
(Date:10/13/2017)... Pa. (PRWEB) , ... October 13, 2017 , ... While ... dark poses a problem. Fortunately, an inventor from Austin, Texas, has identified a solution. ... to medication in darkness or restricted lighting. As such, it eliminates the need to ...
(Date:10/13/2017)... IL (PRWEB) , ... October 13, 2017 , ... ... which established the certification process to promote standards of excellence for the field ... Symposium, scheduled for March 22 – 25, 2018 in Orlando, Florida at the ...
(Date:10/13/2017)... Ill. (PRWEB) , ... October ... ... Edwardsville School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer ... healthcare professionals on guideline updates for the primary prevention of cardiovascular diseases ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes , ... mock evacuation of the facility as part of a disaster drill on October 3rd. ... EMS and Shelton City Emergency Manager, as well as the Connecticut Long Term ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... Pa. , Oct. 12, 2017 ... leader in innovative solutions for injectable drug administration, today ... before the market opens on Thursday, October 26, 2017, ... the results and business expectations at 9:00 a.m. Eastern ... (U.S.) or 253-336-8738 (International). The conference ID is 94093362. ...
(Date:10/10/2017)... Oct. 10, 2017  NDS received FDA 510(k) clearance in May ... battery-powered display stand specifically designed for endoscopy environments. An innovative secondary ... a clinical solution to support the improvement of patient outcomes, procedural ... ... ...
(Date:10/4/2017)... to the Centers for Disease Control and Prevention (CDC), influenza vaccination ... is helping communities across Massachusetts , Connecticut ... flu shots through the end of the month. *Some exclusions ... ... shot is by the end of October, according to the Centers for ...
Breaking Medicine Technology: